Endogenous estrogen metabolites as biomarkers for endometrial cancer via a novel method of liquid chromatography-mass spectrometry with hollow fiber liquid-phase microextraction

Hormone and Metabolic Research

Volumn 47, Issue 2, 2015, Pages 158-164

  Zhao, H ^a   Jiang, Y ^a   Liu, Y ^a   Yun, C ^a   Li, L ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

2 methoxyestradiol; 4 hydroxyestradiol; endometrial cancer; estrogens; LC MS

Indexed keywords

4-HYDROXYESTRADIOL; CATECHOL ESTROGEN; ESTROGEN; TUMOR MARKER;

CLINICAL TRIAL; ENDOMETRIUM TUMOR; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MIDDLE AGED; PROCEDURES; URINE;

CHROMATOGRAPHY, LIQUID; ENDOMETRIAL NEOPLASMS; ESTROGENS; ESTROGENS, CATECHOL; FEMALE; HUMANS; MASS SPECTROMETRY; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84897956026     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1371865     Document Type: Article

References (25)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M. J. Cancer statistics. CA Cancer J Clin: 2008; 58 71 96
2. Yue W., Santen R. J., Wang J. P., Li Y., Verderame M. F., Bocchinfuso W. P., Korach K. S., Devanesan P., Todorovic R., Rogan E. G., Cavalieri E. L. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol: 2003; 86 477 486
3. Tinelli A., Vergara D., Martignago R., Leo G., Malvasi A., Tinelli R. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review. Acta Obstet Gynecol Scand: 2008; 87 1101 1113
4. Salih S. M., Kapur A., Albayrak S., Salama S. A., Magness R. R. Pregnancy ameliorates the inhibitory effects of 2-methoxyestradiol on angiogenesis in primary sheep uterine endothelial cells. Reprod Sci: 2011; 18 858 867
5. Saeed M., Higginbotham S., Gaikwad N., Chakravarti D., Rogan E., Cavalieri E. Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation. Free Radic Biol Med: 2009; 47 1075 1081
6. Zeleniuch-Jacquotte A., Shore R. E., Afanasyeva Y., Lukanova A., Sieri S., Koenig K. L., Idahl A., Krogh V., Liu M., Ohlson N., Muti P., Arslan A. A., Lenner P., Berrino F., Hallmans G., Toniolo P., Lundin E. Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer. Br J Cancer: 2011; 105 1458 1464
7. Mueck A. O., Seeger H. Breast cancer: are oestrogen metabolites carcinogenic? Maturitas: 2007; 57 42 46
8. Huang J., Sun J., Chen Y., Song Y., Dong L., Zhan Q., Zhang R., Abliz Z. Analysis of multiplex endogenous estrogen metabolites in human urine using ultra-fast liquid chromatography-tandem mass spectrometry: a case study for breast cancer. Anal Chim Acta: 2012; 711 60 68
9. Cho J. K., Hong K. Y., Park J. W., Yang H. K., Song S. C. Injectable delivery system of 2-methoxyestradiol for breast cancer therapy using biodegradable thermosensitive poly (organophosphazene) hydrogel. J Drug Target: 2011; 19 270 280
10. Sutherland T. E., Anderson R. L., Hughes R. A., Altmann E., Schuliga M., Ziogas J., Stewart A. G. 2-Methoxyestradiol - a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents. Drug Discov Today: 2007; 12 577 584
11. Ting C. M., Lee Y. M., Wong C. K., Wong A. S., Lung H. L., Lung M. L., Lo K. W., Wong R. N., Mak N. K. 2-Methoxyestradiol induces endoreduplication through the induction of mitochondrial oxidative stress and the activation of MAPK signaling pathways. Biochem Pharmacol: 2010; 15 825 841
12. Wei H. B., Lin J. M., Wu D. N., Zhao L. X., Li Z. J., Ying X. T. Detection of 17β-estradiol in river and human urine by highly sensitive chemiluminescent enzyme immunoassay. Chin Anal Chem: 2007; 35 319 324
13. Jürgen G., Hildgunn B., Per E. L. A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue. J Steroid Biochem Mol Bio: 2000; 72 259 264
14. Zhao H., Sun Z., Xia L., Sun X., Suo Y., Li Y., You J. A novel fluorescence reagent for the analysis of trace free oestradiol and oestriol in urine by reversed-phase high performance liquid chromatography with fluorescence detection and mass spectrometry identification. Chin Chromatogr: 2009; 27 164 168
15. Yamashita K., Okuyama M., Watanabe Y., Honma S., Kobayashi S., Numazawa M. Highly sensitive determination of estrone and estradiol in human serum by liquid chromatography - electrospray ionization tandem mass spectrometry. Steroids: 2007; 72 819 827
16. Zacharia L. C., Dubey R. K., Jackson E. K. A gas chromatography/mass spectrometry assay to measure estradiol, catecholestradiols, and methoxyestradiols in plasma. Steroids: 2004; 69 255 261
17. Xu X., Roman J. M., Veenstra T. D., Van Anda J., Ziegler R. G., Issaq H. J. Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography - mass spectrometry. Anal Chem: 2006; 78 1553 1558
18. Lee D. K., Yoon M. H., Kang Y. P., Yu J., Park J. H., Lee J., Kwon S. W. Comparison of primary and secondary metabolites for suitability to discriminate the origins of Schisandra chinensis by GC/MS and LC/MS. Food Chem: 2013; 141 3931 3937
19. Zhang Z., Zhou D., Lai Y., Liu Y., Tao X., Wang Q., Zhao G., Gu H., Liao H., Zhu Y., Xi X., Feng Y. Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways. Cancer Lett: 2012; 319 89 97
20. Cornel K. M., Kruitwagen R. F., Delvoux B., Visconti L., Van de Vijver K. K., Day J. M., Van Gorp T., Hermans R. J., Dunselman G. A., Romano A. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol. J Clin Endocrinol Metab: 2012; 97 591 601
21. Newbold R. R., Liehr J. G. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res: 2000; 60 235 237
22. Sasaki M., Kaneuchi M., Fujimoto S., Tanaka Y., Dahiya R. CYP1B1 gene in endometrial cancer. Mol Cell Endocrinol: 2003; 28 171 176
23. Li L., Yang W. W., Gao H. Y., Li F., Cheng J. X. Expression of CYP4501B1 and COMT protein in human endometrial cancer. Chinese journal of practical gynecology and obstetrics: 2012; 28 142 145
24. Maran A., Gorny G., Oursler M. J., Zhang M., Shogren K. L., Yaszemski M. J., Turner R. T. 2-methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts. J Cell Biochem: 2006; 99 425 434
25. Li F., Li J. Y., Fu Y., Liu X. J., Li L. The association of Catechol-O-methytransferase activity and endometrial cancer. Tumor: 2012; 32 119 123